convent
hypothesi
concern
initi
acquir
immun
defici
syndrom
aid
epidem
simian
immunodefici
viru
siv
transfer
previous
uninfect
human
within
rel
recent
past
viru
prove
virul
human
evolv
hiv
major
scientif
commun
seem
hold
idea
transfer
accident
transfer
result
nativ
huntingdirect
contact
infect
primat
circa
larg
nonscientist
group
embrac
idea
test
vaccin
congo
circa
caus
transfer
viru
nonhuman
primat
human
obvious
observ
made
research
need
account
seriou
scientif
hypothesi
must
point
hypothesi
leav
mani
unansw
question
nonhuman
primat
subsaharan
africa
appar
place
infect
siv
seem
harm
viru
consid
siv
readili
transmit
human
hiv
readili
transmit
among
human
appar
imposs
elimin
human
human
nonhuman
primat
coexist
subsaharan
africa
mani
thousand
year
ignor
possibl
human
carri
benignsymbiot
strain
hiv
long
time
iron
hiv
viru
kill
cell
infect
eg
tcell
macrophag
immun
system
rather
caus
diseas
kill
uninfect
bystand
cell
tcell
cell
secret
toxin
caus
apoptosi
origin
aid
explain
unusu
type
diseas
hypothesi
publish
address
issu
well
time
issu
import
identifi
specif
action
lead
aid
epidem
malariaaminoquinolin
hypothesi
background
concern
malaria
antimalari
drug
begin
seri
aminoquinolin
deriv
synthes
screen
antimalari
activ
particular
eg
pamaquin
plasmoquin
tm
primaquin
eg
chloroquin
found
prevent
mitig
malari
infect
two
way
one
mode
action
seem
involv
direct
toxic
parasit
erythrocyt
mode
activ
seem
involv
induct
apoptosi
liver
cell
becom
infect
parasit
therebi
prevent
necessari
amplif
parasit
establish
maintain
signific
infect
erythrocyt
red
blood
cell
regard
proapoptot
effect
chloroquin
aminoquinolin
seem
act
suppress
activ
import
transcript
factor
nfkappab
activ
antiapoptot
protein
includ
bclxl
nfkappab
also
play
key
role
reactiv
latent
hiv
inde
chloroquin
shown
interact
nfkappab
appar
enhanc
bind
specif
segment
dna
way
prevent
nfkappab
act
transcript
factor
effect
chloroquin
bind
nfkappab
dna
may
basi
chloroquin
suppress
hiv
replic
chloroquin
also
affect
express
tnf
seem
potent
role
eg
chloroquin
chloroquin
elimin
malaria
infect
cell
liver
although
appear
prevent
becom
matur
schizont
prematur
apoptosi
howev
toxic
host
human
difficult
achiev
safe
effect
dose
chloroquin
actual
build
blood
stream
prove
easier
achiev
continu
protect
long
period
time
chloroquin
histori
develop
discuss
detail
consid
import
ecolog
evolutionari
context
subsaharan
africa
domin
featur
plagu
malaria
primat
malaria
continu
plagu
primat
anim
least
year
hyperendem
area
central
africa
malaria
parasit
substanti
reduc
number
children
make
reproduct
age
attrit
produc
ecolog
stress
human
human
known
incur
signific
evolutionari
chang
adapt
ecolog
stress
caus
malaria
exampl
sicklecel
trait
human
subsaharan
africa
produc
lifethreaten
debilit
diseas
yet
retain
human
popul
confer
protect
malaria
area
globe
malaria
problem
notic
affect
human
evolut
extrem
problem
call
extrem
measur
lifecycl
malaria
parasit
quit
complex
human
form
parasit
inject
mosquito
go
directli
erythrocyt
red
blood
cell
enough
success
evad
immun
system
surviv
normal
attrit
erythrocyt
thu
initi
malaria
infect
invad
liver
hepatocyt
convert
factori
make
thousand
copi
malaria
organ
infect
liver
cell
call
schizont
fill
parasit
burst
schizont
begin
major
cycl
fever
associ
diseas
parasit
releas
liver
infect
erythrocyt
also
use
multipli
period
erythrocyt
schizont
burst
new
attack
chill
fever
adult
immun
system
attrit
erythrocyt
gradual
get
upper
hand
parasit
symptom
usual
elimin
period
year
two
point
need
made
first
cell
place
metabol
genotox
mechan
stress
usual
undergo
spontan
apoptosi
program
cell
disassembl
recycl
ie
suicid
case
intracellular
parasit
apoptosi
newli
infect
host
cell
desir
defens
establish
infect
burden
whole
anim
obvious
malaria
parasit
success
reproduc
mani
copi
distort
expand
hepatocyt
mean
master
art
block
apoptosi
host
cell
suppress
apoptosi
intracellular
parasit
usual
accomplish
either
produc
parasit
mimic
host
antiapoptot
protein
induc
host
cell
overexpress
antiapoptot
protein
suppress
host
proapoptot
protein
second
arm
race
intracellular
parasit
immun
system
tcell
tcell
evolv
array
weapon
includ
releas
sever
protein
target
death
receptor
surfac
cell
eg
tnf
even
abil
spew
toxic
nitrou
oxid
produc
nitrou
oxid
synthesas
no
system
invad
propos
desper
situat
improv
surviv
face
malaria
might
achiev
individu
carri
tcell
arm
unusu
potent
proapoptot
protein
henc
hyperendem
malaria
area
fast
evolv
retrovirus
provid
toxic
agent
especi
proapoptot
protein
may
found
home
tcell
develop
symbiot
relationship
howev
delic
balanc
benefit
overdos
appar
maintain
simpl
mechan
viralinfect
tcell
becom
toxic
kill
popul
primat
tcell
retrovirus
ptrv
normal
limit
lethal
toxin
infect
cell
howev
infect
host
cell
acquir
much
protect
intern
viral
toxin
rel
bystand
cell
bystand
tcell
preferenti
kill
potenti
lead
immun
defici
toxin
may
also
directli
kill
nonimmun
cell
first
proposit
plausibl
would
difficult
prove
presum
hiv
exist
symbiot
relationship
human
primat
malaria
endem
area
long
time
thousand
year
likelihood
virus
cross
recross
speci
barrier
mani
time
gener
notic
advers
effect
idea
consist
idea
discuss
levin
evolut
microparasit
relev
inde
primat
tcell
lymphotrop
retroviru
ptlv
repeatedli
cross
human
primat
thousand
year
central
africa
evid
chloroquin
interact
nfkappab
give
credenc
hypothesi
chloroquin
action
hiv
virus
facilit
apoptosi
infect
cell
thu
develop
chloroquineresist
ptrv
hiv
would
requir
develop
enhanc
resist
infect
cell
apoptosi
second
proposit
proapoptot
chloroquin
caus
evolut
hiv
virus
toward
resist
mode
action
chloroquin
gener
agre
malaria
protozoa
enter
erythrocyt
howev
consid
proapoptot
effect
fact
chloroquin
use
prevent
malari
infect
start
liver
would
seem
odd
chloroquin
effect
parasit
liver
chloroquin
certainli
biochem
effect
express
nfkappab
downstream
antiapoptot
protein
agent
eg
primaquin
cure
establish
liver
infect
toxic
chloroquin
moder
toxic
bioconcentr
excret
slowli
thu
dose
schedul
prophylaxi
flexibl
well
known
malaria
parasit
develop
resist
chloroquin
year
intens
use
also
well
known
hiv
develop
resist
antiaid
drug
quickli
found
chloroquin
effect
hiv
infect
thu
seem
selfevid
chloroquin
would
caus
evolut
hiv
strain
toward
resist
drug
cours
would
also
true
human
infect
benign
strain
ptrv
defin
pleas
note
affect
chloroquin
hiv
coronaviru
experiment
observ
specul
although
mode
action
discuss
first
proposit
may
wrong
rest
hypothesi
would
unaffect
inform
presenc
retrovirus
person
display
aid
symptom
readili
avail
note
human
gener
presum
free
ptrv
except
case
hivaid
much
discuss
date
assign
last
common
ancestor
known
aidscaus
strain
hiv
ptrv
unfortun
much
import
inform
overlook
briefli
assum
mutat
caus
erron
transcript
rna
dna
templat
princip
reason
diverg
hiv
ptrv
strain
phylogenet
tree
develop
absolut
timelin
creat
almost
sampl
collect
extrapol
back
time
accompani
progress
greater
uncertainti
consensu
last
common
ancestor
aidscaus
strain
estim
confid
interv
similar
result
obtain
salemi
et
al
show
transmiss
predecessor
hiv
ie
ptrv
human
could
come
earli
late
late
xvii
centuri
strain
began
diverg
absolut
uncertainti
date
thu
quit
larg
rel
error
fairli
small
thu
special
attent
appli
qualit
featur
phylogenet
tree
fig
korber
et
al
lot
import
inform
recal
mutat
rna
viru
continu
though
constant
howev
actual
evolut
aidscaus
strain
hiv
ptrv
follow
distinct
pattern
either
version
prevail
hypothesi
would
presum
produc
continu
random
branch
tree
contrari
expect
evolut
aidscaus
strain
hiv
ptrv
initi
fast
first
four
major
branch
tree
cjh
bd
f
split
soon
last
common
ancestor
ie
subsequ
strain
h
jc
split
hjc
b
c
split
bc
littl
happen
multipl
split
strain
occur
intens
period
split
mysteri
stop
around
explain
qualit
pattern
mention
main
sourc
uncertainti
absolut
date
sampl
time
uncertainti
random
recombin
would
suggest
earlier
date
earli
latenc
viru
would
suggest
earlier
date
late
regardless
note
first
antimalari
drug
pamaquin
plasmoquin
tm
synthes
ig
farben
bayer
germani
almost
immedi
test
kinshasa
leopoldvil
congo
belgium
activ
school
tropic
medicin
date
specif
address
diseas
free
state
congo
plasmoquin
tm
continu
investig
auspic
leagu
nation
throughout
thu
date
target
korber
et
al
agre
well
arriv
kinshasa
congo
search
antimalari
drug
begin
chloroquin
deriv
synthes
laboratori
bayer
ig
farben
germani
candid
antimalari
drug
chloroquin
origin
call
resochin
german
dr
jb
rice
activ
antimalari
drug
research
gave
rare
detail
earli
histori
testimoni
court
case
accord
rice
chloroquin
deriv
superfici
screen
canari
german
lot
work
avian
malaria
found
activ
malaria
dr
kikuth
dr
kikuth
sent
sampl
drug
candid
dr
seolli
rome
itali
detail
toxicolog
test
dr
seolli
deem
chloroquin
resochin
toxic
human
use
instead
pursu
relat
compound
design
sontochin
sterl
drug
inc
dr
rice
work
crosslicens
agreement
ig
farben
receiv
inform
late
pursu
chloroquin
japanes
invad
java
us
depriv
sourc
quinin
launch
high
prioriti
program
find
new
antimalari
drug
howev
rice
becom
interest
chloroquin
involv
postwar
review
german
technolog
look
antimalari
use
plan
continu
war
japan
us
review
test
us
numer
compound
select
chloroquin
approv
us
food
drug
administr
refer
use
congo
prior
found
howev
possibl
may
test
wwii
start
us
alon
pursu
chloroquin
chloroquin
design
sn
test
prophylact
agent
malaria
kinshasa
congo
work
appar
facilit
princ
leopold
institut
tropic
medicin
establish
congo
dock
antwerp
belgium
appear
coupl
year
test
kinshasa
work
stop
attent
europ
turn
world
health
organ
plan
field
test
algeria
itali
portug
andor
yugoslavia
mention
made
central
africa
congo
european
busi
tri
recov
war
go
far
home
initi
field
trial
chloroquin
use
visitor
congo
congo
unlik
nativ
popul
access
chloroquin
howev
world
health
organ
launch
worldwid
erad
campaign
use
ddt
kill
mosquito
chloroquin
reduc
number
infect
carrier
subsaharan
africa
erad
mosquito
ddt
consid
impract
chloroquin
made
wide
avail
scale
program
mani
order
magnitud
larger
anyth
come
although
erad
program
accept
failur
extens
use
chloroquin
continu
central
africa
chloroquineresist
malaria
reach
congo
correl
histori
antimalari
drug
central
africa
evolut
aidscaus
hiv
ptrv
remark
would
unexpect
given
known
effect
chloroquin
hiv
note
recent
attribut
entir
histori
hiv
ptrv
evolut
chloroquin
unnecessari
unlik
view
histori
pamaquin
plasmoquin
tm
overal
evolut
human
strain
ptrv
exist
probabl
earli
without
caus
diseas
probabl
got
start
field
test
pamaquin
circa
modifi
viru
strain
presum
initi
hand
nativ
peopl
viru
particip
test
near
kinshasa
congo
situat
readili
explain
known
strain
fond
kinshasa
nowher
els
peopl
probabl
transfer
modifi
viru
nativ
via
sexual
contact
antimalaria
program
initi
peopl
carri
modifi
viru
still
caus
aid
expos
select
pressur
intens
use
chloroquin
aidscaus
strain
soon
emerg
aidscaus
strain
stop
evolv
longer
expos
chloroquin
inde
withdraw
chloroquin
mani
case
like
allow
clinic
aid
develop
among
peopl
infect
viru
case
virus
sampl
carri
peopl
malaria
endem
area
andor
level
chloroquin
use
drop
ie
chloroquin
use
treat
individu
malaria
victim
rather
provid
prophylaxi
lack
fund
lack
util
similar
pattern
evolut
observ
discuss
elsewher
intracellular
parasit
virus
bacteria
protozoa
fungi
like
evolv
area
endem
malaria
chloroquineresist
malaria
time
develop
particular
histori
sar
map
similar
hivaid
deadli
strain
ebola
viru
also
emerg
right
timefram
area
cover
antimalari
program
congo
sudan
philippin
sort
bystand
effect
found
hiv
lead
idea
similar
event
may
start
proapoptot
stress
remov
aidscaus
strain
hiv
ptrv
muller
ratchet
suggest
diseasecaus
strain
soon
disappear
individu
might
treat
agent
suppress
antiapoptot
protein
host
cell
kill
kill
bystand
cell
elimin
latent
virus
agent
need
activ
host
cell
cours
chloroquin
antihiv
activ
pamaquin
might
work
better
although
might
prove
riski
aid
like
syndrom
like
induc
sivinfect
nonhuman
primat
intens
dose
chloroquin
period
year
pattern
select
mutat
might
observ
within
year
diseas
would
probabl
manifest
chloroquin
treatment
stop
